These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 28875848)

  • 1. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
    Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
    Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy.
    Elzoghby AO
    Curr Pharm Des; 2017; 23(35):5211-5212. PubMed ID: 29110600
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
    Kumar L; Baldi A; Verma S; Utreja P
    Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
    Zhang Y; Zhang P; Zhu T
    Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.
    Gothwal A; Khan I; Gupta U
    Pharm Res; 2016 Jan; 33(1):18-39. PubMed ID: 26381278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
    Pathak K; Akhtar N
    Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.
    Bolhassani A; Javanzad S; Saleh T; Hashemi M; Aghasadeghi MR; Sadat SM
    Hum Vaccin Immunother; 2014; 10(2):321-32. PubMed ID: 24128651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
    Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellulose-based Nanocarriers as Platforms for Cancer Therapy.
    Meng LY; Wang B; Ma MG; Zhu JF
    Curr Pharm Des; 2017; 23(35):5292-5300. PubMed ID: 29086678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulate carriers: an emerging tool for breast cancer therapy.
    Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R
    J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
    Kanugo A; Gautam RK; Kamal MA
    Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.